Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session

NCT03904836 is registered in ClinicalTrials.gov with Maisonneuve-Rosemont Hospital as lead sponsor.

NCT NCT03904836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03904836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session
Lead sponsor
Maisonneuve-Rosemont Hospital
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2019
Completion date
December 31, 2019
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal dialysis, renal failure, chronic